| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 280.553.201 $ | +64.280.275 $ | +37,0 % | 6 | 216.272.926 $ | +39.869.370 $ | +28,8 % | 6 | 176.403.556 $ | +61.646.922 $ | +98,0 % | 6 | ||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 131.060.338 $ | +2.319.652 $ | +1,8 % | 1 | 128.740.686 $ | +12.990.051 $ | +11,2 % | 1 | 115.750.635 $ | +40.258.885 $ | +53,3 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Neutral | 99.760.828 $ | +54.671.551 $ | +121,3 % | 1 | 45.089.277 $ | +26.656.263 $ | +144,6 % | 1 | 18.433.014 $ | +4.573.605 $ | +33,0 % | 1 |
| ALX ONCOLOGY HOLDINGS INC | ALXO | → 0 | Schwach | 25.833.699 $ | +14.872.784 $ | +135,7 % | 1 | 10.960.915 $ | -6.789.948 $ | -38,3 % | 1 | 17.750.863 $ | +13.724.424 $ | +340,9 % | 1 |
| Harmony Biosciences Holdings, Inc. | HRMY | → 0 | Stark | 13.702.324 $ | -4.603.315 $ | -25,1 % | 1 | 18.305.639 $ | +4.823.452 $ | +35,8 % | 1 | 13.482.187 $ | -1.976.343 $ | -12,8 % | 1 |
| Lyell Immunopharma, Inc. | LYEL | → 0 | Neutral | 6.774.202 $ | -3.620.112 $ | -34,8 % | 1 | 10.394.314 $ | +2.705.015 $ | +35,2 % | 1 | 7.689.299 $ | +3.503.745 $ | +83,7 % | 1 |
| Artiva Biotherapeutics, Inc. | ARTV | → 0 | Schwach | 3.421.810 $ | +639.715 $ | +23,0 % | 1 | 2.782.095 $ | -515.463 $ | -15,6 % | 1 | 3.297.558 $ | +1.562.606 $ | +90,1 % | 1 |
| 280.553.201 $ | +64.280.275 $ | +37,0 % | 6 | 216.272.926 $ | +39.869.370 $ | +28,8 % | 6 | 176.403.556 $ | +61.646.922 $ | +98,0 % | 6 | ||||